Mysore/Mysuru: Stating that the second wave of COVID-19 pandemic is dangerous, Deputy Commissioner (DC) Rohini Sindhuri has asked the citizens to be extra careful. Speaking live on Facebook page of Department of Information and Public Relations yesterday, she said the symptoms of COVID-19 second wave were totally different and people must not neglect any kind…
Fake Remdesivir injection racket: CCB Cops intensify investigation
April 25, 2021Mysore/Mysuru: The City Crime Branch (CCB) Police, who are investigating the sale of fake Remdesivir injections after they busted the racket by arresting three persons, have intensified their investigation. CCB Police had arrested Girish, a staff nurse at a private hospital in city after raiding his house where he used to manufacture the fake injections…
Fake Remdesivir case: Two medical representatives arrested
April 21, 2021Mysore/Mysuru: The City Crime Branch (CCB) Police, who are investigating the sale of fake Remdesivir injections, have arrested two medical representatives yesterday, thus bringing the total number of arrests in this case to three. The CCB Police on Apr. 19 had arrested prime accused Girish, a nurse at a private hospital in city for manufacturing…
Fake Remdesivir injections
April 20, 2021One arrested; Four including two medical representatives taken into custody; Accused sold 800-900 injections after filling it with cheap antibiotics, saline water Mysore/Mysuru: The City Police have busted a fake Remdesivir racket by arresting a staff nurse from a reputed hospital who used to source empty vials of the drug, fill them with cheap antibiotics…
Exorbitantly priced in the first wave too
April 20, 2021Mysore/Mysuru: Even during the first wave of COVID-19 last year, there was a huge demand for Remdesivir injections and there was a shortage in cities including Mysuru. When the pandemic was at its peak, each vial that costs Rs. 4,500 to Rs. 5,000 was sold at a whopping Rs. 1 lakh. The drug was sold…
Drugs Control Officer warns against blackmarketing of Remdesivir
April 19, 2021Mysore/Mysuru: Mysuru-Mangaluru Region Deputy Drug Controller Nazeer Ahmed has warned of stern action against blackmarketing of ‘Remdesivir’ vaccine, which is a crucial medicine for treatment of COVID-19. Speaking to Star of Mysore, Nazeer Ahmed said that severe action against those who create artificial shortage of ‘Remdesivir’ vaccine by stocking for huge profits. Pointing out that…
Centre cuts Remdesivir price from Rs. 5,400 to Rs. 3,500
April 17, 2021New Delhi: The Government of India has slashed the price of Remdesivir from Rs. 5,400 to Rs. 3,500 for the benefit of Corona patients and has supplied 6.69 lakh bottles to various States in the last five days, said Union Minister for Chemicals and Fertilizers D.V. Sadananda Gowda (DVS). He held a meeting with Mansukh…
Government appoints Nodal Officer for Remdesivir supply to Private Hospitals
April 15, 2021Bengaluru: Following complaints about non-availability of Remdisiver injection to treat Corona patients in Private Hospitals, the State Government is facilitating supplies meant for privately admitted patients in private hospitals. Accordingly, a Nodal Officer has been appointed whose contact details are as follows: Kempaiah Suresh, Deputy Drugs Controller-1, Regional Office, Bengaluru. Mob: 70198-61430 or 90357-96385; e-mail:…
Remdesivir effective in COVID-19 treatment: Dr. C.N. Manjunath
October 28, 2020Bengaluru: Dr.C.N. Manjunath, Cardiologist and Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, has said the use of antiviral drug Remdesivir has been very effective in the treatment of COVID-19 patients. Participating in a virtual panel discussion on Infectious Diseases Control organised by e-Health magazine published by Elets Technomedia recently, he said the…
Jubilant launches ‘JUBI-R’ (remdesivir) for COVID-19 treatment in India
August 4, 2020Mysore/Mysuru: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary, Jubilant Generics Limited (Jubilant), has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of Rs. 4,700 per vial of 100 mg (lyophilized injection). The Company will make the drug…
Recent Comments